Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Your business in court: 2009-2010.

Reiss JB, Hall CR, Wartman GJ.

Food Drug Law J. 2011;66(2):139-81, i.

PMID:
24505838
2.

Your business in court and at federal agencies: 2010 - 2011.

Reiss JB, Crowder D, Simons B, Pleskov I, Davis T, Nugent P.

Food Drug Law J. 2012;67(2):243-92, iii.

PMID:
24620420
3.

Your business in court and at Federal agencies: 2011-2012.

Reiss JB, Crowder D, McCabe B, DeFeo M, Rifin M, Talbot M.

Food Drug Law J. 2013;68(1):1-51, i.

PMID:
24640636
5.

Buckman extended: federal preemption of state fraud-on-the-FDA statutes.

Gaddis CA.

Food Drug Law J. 2014;69(1):113-36, iii.

PMID:
24772688
6.

The impact of Wyeth v. Levine on FDA regulation of prescription drugs.

Ausness RC.

Food Drug Law J. 2010;65(2):247-83, i-ii.

PMID:
24475542
8.
10.

Unsettling drug patent settlements: a framework for presumptive illegality.

Carrier MA.

Mich Law Rev. 2009 Oct;108(1):37-80.

PMID:
20535881
11.

Prescription drug advertising--should states regulate what is false and misleading?

Shaeffer J.

Food Drug Law J. 2003;58(4):629-48. No abstract available.

PMID:
15027454
12.

Corporate compliance programs: risk management for the future.

Snyder LS, Lewis EA.

Physician Exec. 1995 Sep;21(9):40-1.

PMID:
10151481
13.

Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.

Reichertz PS.

Food Drug Law J. 1996;51(3):355-65. No abstract available.

PMID:
11797712
14.

Implementing US-style anti-fraud laws in the Australian pharmaceutical and health care industries.

Faunce TA, Urbas G, Skillen L.

Med J Aust. 2011 May 2;194(9):474-8.

PMID:
21534908
15.

Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies.

Nguyen D, Seoane-Vazquez E, Rodriguez-Monguio R, Montagne M.

BMC Health Serv Res. 2013 Jan 22;13:27. doi: 10.1186/1472-6963-13-27.

16.

Defending an emerging threat: consumer fraud class action suits in pharmaceutical and medical device products-based litigation.

Leghorn JJ, Allen C Jr, Brewington T.

Food Drug Law J. 2006;61(3):519-38. No abstract available.

PMID:
16989037
18.

Your business in court--2005.

Reiss JB, Levy MC, Newhart AB.

Food Drug Law J. 2006;61(2):279-93. No abstract available.

PMID:
16903033
19.

Supplemental Content

Support Center